Urogen Pharma (NASDAQ:URGN) Q3 2026 Earnings Call
Urogen Pharma (NASDAQ:URGN) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.
- Company
- Urogen Pharma Ltd. (NASDAQ:URGN)
- Period
- Q3 2026 earnings call
- Date
- Wed, Nov 4, 2026, 10:00 AM ET
On 6ix: 6ix.com/event/urogen-pharma-ltd-urgn-q3-2026-earnings-call
Latest news releases
- NASDAQ:URGN — UroGen Pharma to Present at the Guggenheim Securities 3rd Annual Healthcare Innovation Conference · Tue, Nov 3, 2026
- NASDAQ:URGN — UroGen Announces First Patient Dosed in Phase 1 Trial of UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer · Mon, Nov 2, 2026